« Previous
Next »
European Journal of Cancer
Volume 45, Issue 1
, Pages
99-106
, January 2009
Renal function after ifosfamide, carboplatin and etoposide (ICE) chemotherapy, nephrectomy and radiotherapy in children with wilms tumour
-
Therapy schema. V
=
vincristine 1.5
mg/m2 (maximum dose, 2
mg); D
=
dactinomycin 0.6
mg/m2 (maximum dose, 2
mg); A
=
doxorubicin (Adriamycin) 25
mg/m2; ICE chemotherapy: C
=
carboplatin, dosage based on GFR to tarTherapy schema. V
=
vincristine 1.5
mg/m2 (maximum dose, 2
mg); D
=
dactinomycin 0.6
mg/m2 (maximum dose, 2
mg); A
=
doxorubicin (Adriamycin) 25
mg/m2; ICE chemotherapy: C
=
carboplatin, dosage based on GFR to target an AUC of 6
mg/ml
min on day 1; E
=
etoposide 100
mg/m2 per day on days 2–4; I
=
ifosfamide 2
g/m2 per day on days 2–4. -
Bland–Altman plot to assess agreement between GFR and estimated creatinine clearance (n=35 pairs). The solid line represents the bias of the difference between pairs (17.8ml/min per 1.73m2) and the daBland–Altman plot to assess agreement between GFR and estimated creatinine clearance (n
=
35 pairs). The solid line represents the bias of the difference between pairs (17.8
ml/min per 1.73
m2) and the dashed lines represent the 95% confidence interval. -
Renal tubular function was longitudinally assessed by measuring urinary magnesium excretion (a), renal tubular threshold for phosphate (b), and urinary β2-microglobulin (c) in patients with Wilms tumoRenal tubular function was longitudinally assessed by measuring urinary magnesium excretion (a), renal tubular threshold for phosphate (b), and urinary β2-microglobulin (c) in patients with Wilms tumour treated with ICE. Shaded areas (a,
b) represent the normal range.
PII: S0959-8049(08)00749-1
doi: 10.1016/j.ejca.2008.09.017
© 2008 Elsevier Ltd. All rights reserved.
« Previous
Next »
European Journal of Cancer
Volume 45, Issue 1
, Pages
99-106
, January 2009
